Peer Review reports
From: Targeted elimination of Vancomycin resistance gene vanA by CRISPR-Cas9 system
| Original Submission | ||
|---|---|---|
| 2 Oct 2023 | Submitted | Original manuscript |
| 16 Oct 2023 | Reviewed | Reviewer Report |
| 30 Oct 2023 | Reviewed | Reviewer Report |
| 10 Nov 2023 | Author responded | Author comments - wei Liang |
| 12 Nov 2023 | Author responded | Author comments - wei Liang |
| Resubmission - Version 2 | ||
| 10 Nov 2023 | Submitted | Manuscript version 2 |
| 16 Nov 2023 | Author responded | Author comments - wei Liang |
| Resubmission - Version 3 | ||
| 16 Nov 2023 | Submitted | Manuscript version 3 |
| 18 Nov 2023 | Reviewed | Reviewer Report |
| 18 Nov 2023 | Reviewed | Reviewer Report |
| 22 Nov 2023 | Author responded | Author comments - wei Liang |
| Resubmission - Version 4 | ||
| 22 Nov 2023 | Submitted | Manuscript version 4 |
| 24 Nov 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 28 Nov 2023 | Editorially accepted | |
| 4 Dec 2023 | Article published | 10.1186/s12866-023-03136-w |
You can find further information about peer review here.